Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): A$0.04960

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is A$0.05086. In 2024 the company made an earnings per share (EPS) of A$0.03732 an increase over its 2023 EPS that were of A$0.02536.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2024	A$0.03732	47.17%
2023	A$0.02536	-9.68%
2022	A$0.02807	-83.86%
2021	A$0.17	440.46%
2020	A$0.03218	7.54%
2019	A$0.02992	-70.37%
2018	A$0.10	254.37%
2017	A$0.02849	41.55%
2016	A$0.02013	2.59%
2015	A$0.01962	17.63%
2014	A$0.01668	45.97%
2013	A$0.01143	16.34%
2012	A$0.009823	93.4%
2011	A$0.005079	-20.02%
2010	A$0.006350	33.16%
2009	A$0.004769	774.72%
2008	A$0.0005452	-79.69%
2007	A$0.002685	58.8%
2006	A$0.001691	-91.05%
2005	A$0.01888	723.97%
2004	A$0.002292	105.48%
2003	A$0.001115	-67.27%
2002	A$0.003408	-8.26%
2001	A$0.003714	17.18%
2000	A$0.003170	-1.9%
1999	A$0.003231

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)